Novartis AG Stock price

Equities

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe 04:09:21 2024-03-19 am EDT 5-day change 1st Jan Change
85.21 CHF -0.37% Intraday chart for Novartis AG -3.68% +0.78%
Sales 2024 * 48.15B 42.82B Sales 2025 * 50.2B 44.64B Capitalization 211B 188B
Net income 2024 * 10.05B 8.94B Net income 2025 * 11.04B 9.82B EV / Sales 2024 * 4.63 x
Net Debt 2024 * 11.49B 10.22B Net Debt 2025 * 10.14B 9.01B EV / Sales 2025 * 4.41 x
P/E ratio 2024 *
18.8 x
P/E ratio 2025 *
16.6 x
Employees 76,057
Yield 2024 *
3.87%
Yield 2025 *
4%
Free-Float 86.29%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Novartis AG

1 day-0.13%
1 week-3.68%
Current month-4.43%
1 month-3.29%
3 months+0.32%
6 months-7.05%
Current year+0.78%
More quotes
1 week
85.16
Extreme 85.16
87.60
1 month
85.16
Extreme 85.16
92.15
Current year
85.16
Extreme 85.16
94.52
1 year
75.35
Extreme 75.35
94.77
3 years
72.84
Extreme 72.84
94.77
5 years
65.09
Extreme 65.09
96.38
10 years
65.09
Extreme 65.09
103.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 04-12-31
Director of Finance/CFO 59 02-12-31
Chief Tech/Sci/R&D Officer 62 22-05-15
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 65 20-02-27
Chairman 68 12-12-31
More insiders
Date Price Change Volume
24-03-18 85.53 -0.13% 2 529 565
24-03-15 85.64 -1.34% 16,109,810
24-03-14 86.8 -0.38% 2,717,302
24-03-13 87.13 -0.53% 3,547,186
24-03-12 87.59 -1.36% 3,766,221

Delayed Quote Swiss Exchange, March 18, 2024 at 12:31 pm EDT

More quotes
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (81.7%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.; - generic drugs (18.3%; Sandoz). Net sales are distributed geographically as follows: Europe (36.5%), the United States (34.9%), Asia/Africa/Australasia (20.9%), Canada and Latin America (7.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
96.46 USD
Average target price
109 USD
Spread / Average Target
+13.00%
Consensus
  1. Stock
  2. Equities
  3. Stock Novartis AG - Swiss Exchange